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Prenatal exposure to nicotine modifies kidney weight and blood
pressure in genetically susceptible rats: A case of gene-environ-
ment interaction.
Background. Epidemiologic studies suggest that in utero ex-
posure to maternal smoking is associated with elevated blood
pressure (BP) later in life. Our aims were: (1) to examine
effects of intrauterine exposure to nicotine on BP and hyper-
tension target-organ size in rats; and (2) to investigate whether
such effects depend on genetic background, by studying two
genetically distinct strains of rats: the spontaneously hyperten-
sive rat (SHR) and the normotensive Brown Norway (BN) rat.
Methods. Nicotine or saline was administered to dams via sub-
cutaneous osmotic minipumps throughout gestation. In nine-
week-old male offspring, we measured BP and heart rate, as-
sessed the weight of kidneys and heart, and determined fasting
levels of glucose, insulin, triglycerides (TG), and cholesterol.
We also measured gene expression of the insulin-like growth
factor (IGF) system in the liver and kidneys.
Results. SHR and BN offspring differed in their response
to intrauterine exposure to nicotine. SHR exposed to nicotine
(vs. saline) exhibited higher BP (P  0.02) and serum choles-
terol levels (P  0.01), and lower kidney weight (P  0.0001).
In contrast, BN rats did not demonstrate differences between
the nicotine and saline groups in these variables, but the nico-
tine-exposed BN rats showed a significant up-regulation in the
gene expression of IGF-1 in the liver (P  0.0001) and IGF
receptor in the kidney (P  0.006).
Conclusion. These results suggest that intrauterine exposure
to nicotine alters the cardiovascular system depending on the
genetic background and, as such, supports the notion that the
intrauterine environment interacts with genes in determining
an individual’s health later in life.
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A growing body of evidence suggests that an adverse
intrauterine environment, such as poor nutrition, stress,
and exposure to noxious toxins and drugs may play an
important role in the development of common chronic
diseases, including hypertension [1, 2], diabetes [2, 3], and
obesity [4]. It has been postulated, originally by Barker
et al [5], that fetuses adapt to environmental influences
by changing their physiology, and in doing so, they irre-
versibly alter the structure and function of specific tissues
in the body. The changes are likely beneficial/protective
in the short-term, but they may be maladaptive in the
long run. Some of these changes include augmented insu-
lin resistance [3], modified reactivity of the hypothala-
mus-pituitary-adrenal axis [6], and reduction in the size/
function of the kidneys, pancreas, and liver [7, 8].
In developed countries, maternal tobacco smoking dur-
ing pregnancy is the leading cause of intrauterine growth
retardation [9]. Recent epidemiologic studies have dem-
onstrated an association between maternal smoking dur-
ing pregnancy and elevated blood pressure (BP) in the
offspring later in life [10–12]. Thus, a significant positive
correlation was observed between the number of ciga-
rettes smoked by mothers during pregnancy and the BP
of their babies during the first 72 hours after birth. In
addition, BP was significantly higher in neonates of mothers
who smoked more than 15 cigarettes a day than in the
neonates of mothers who did not smoke. The two groups
also differed in birth weight; as expected, the neonates
of smoking mothers weighed significantly less than the
neonates of non-smoking mothers. The observed differ-
ence in BP was present on reexaminations at 4 and 9
months, and at 12 months, but not at 24 months; the
difference in body weight (BW) was seen only at birth
[13]. In studies of older children, maternal smoking in
pregnancy was likewise associated with lower birth-
weight and higher BP later in life. These investigations,
which included children and adolescents aged one to six
years [10], 7.5 to 8 years [11], and 9 to 18 years [12],
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showed that the relationship of maternal smoking to BP
is stronger for systolic blood pressure (SBP) than for dia-
stolic blood pressure (DBP) [11, 12]. Some other studies
did not, however, find evidence for the association be-
tween maternal smoking during pregnancy and the child’s
blood pressure [14, 15].
The impact of maternal smoking on the developing
fetus is complex. First, tobacco smoke may affect the
fetus in several ways [16]. Inhaled nicotine induces vaso-
constriction of the uteroplacental vasculature, which
leads to uteroplacental underperfusion and, in turn, de-
creased flow of nutrients and oxygen to the fetus. In-
creased levels of carboxyhemoglobin reduce tissue oxy-
genation of the fetus. Nicotine suppresses the mother’s
appetite, leading to poor nutrition of the mother and
fetus. Nicotine causes alterations in the cellular growth
and activity of the central and peripheral nervous sys-
tems [17]. Second, tobacco smoking is frequently associ-
ated with epiphenomena, such as risky behavior, co-abuse
of other substances, poor prenatal care, and low socio-
economic status [17], which themselves may exert ad-
verse effects on the developing fetus. Finally, interindi-
vidual variability in genetic background is likely to modify
the response of the fetus to tobacco smoke (gene-envi-
ronment interactions) [18].
To disentangle at least some of the above complexities,
we carried out the present study in experimental animals,
focusing on the effects of nicotine administered via sub-
cutaneous osmotic minipumps. The specific aims of the
study were: (1) to examine whether intrauterine expo-
sure to nicotine affects BP, hypertension target-organ
size, and cardiovascular risk factors in rats; and (2) to
investigate if these potential effects are modified by ge-
netic background. To assess the latter, two genetically
distinct inbred strains of rats were studied, the spontane-
ously hypertensive rat (SHR) and the normotensive
Brown Norway (BN) rat. Given the fact that previous
studies in humans found an association between prenatal
exposure to maternal cigarette smoking and increased
BP as early as in childhood and adolescence [12], we
examined the offspring before they reached full maturity
(at the age of nine weeks).
METHODS
To mimic nicotine exposure levels of human fetuses
whose mothers smoke during pregnancy, we employed
a previously developed rat model of intrauterine expo-
sure to nicotine [17]. In brief, 12 SHR and 20 BN females
(16- to 20-week-old proven breeders, Harlan-Teklad, In-
dianapolis, IN, USA) were allowed mating for 24 hours.
On the fourth day after mating, osmotic minipumps
(Type 2ML2, Alza Corp., Palo Alto, CA, USA) were
surgically inserted as follows. The rats were lightly anes-
thetized with isoflurane, and an incision was made on
their back to insert the osmotic minipump subcutane-
ously. The incision was closed with four sutures. Half of
the females (6 SHR and 10 BN) were implanted with
minipumps containing nicotine bitartrate (Sigma Chemical
Co., St. Louis, MO, USA) in a concentration of 51 mg/mL
of bacteriostatic water (Abbott Laboratories, North Chi-
cago, IL, USA), and half of the females (6 SHR and 10
BN) were implanted with minipumps containing only
bacteriostatic water (vehicle) and an equivalent concen-
tration of sodium bitartrate. The flow rate of the mini-
pumps was 125 L/day. The minipumps infuse nicotine
continuously for 17 days (from the 4th to the 21st day
after mating) at a dose of 2.1 mg of nicotine free-base
per day. In a 350 g weight rat, this corresponds to a dose
rate of 6 mg/kg/day and a nicotine intake of heavy ciga-
rette smoking in humans [17]. During gestation, pregnant
females were housed individually with 12-hour light/dark
cycles. They were provided rat chow and water ad libi-
dum. Nicotine treatment did not affect length of gesta-
tion, as all of the pregnancies reached their full term (21
days). In both strains, there was a nonsignificant trend
toward a decrease in litter size in the nicotine compared
to the saline groups [SHR, 9.8  0.4 (saline) and 7.1 
0.4 (nicotine) pups/litter; BN, 7.3  0.5 (saline) and 6.3 
0.7 (nicotine) pups/litter].
Pups born to the dams were kept with their mothers
until weaning (21 days). At that time, female pups were
sacrificed, and male pups [SHR, N  13 (nicotine) and
N  12 (saline); BN, N  12 (nicotine) and N  12
(saline)] were transferred to cages where they were housed
in groups of two. At the age of nine weeks, they were
subjected to BP and heart rate (HR) measurement by
the tail-cuff method (Blood Pressure Analyzer, IITC Life
Science, Woodlands Hills, CA, USA). On day 1, the rats
were immobilized at room temperature for 30 minutes.
During this time, a tail-cuff was inflated three times. On
day 2, the rats underwent the same procedure with the
number of tail-cuff inflations increased to five. On day
3 (the measurement day), the animals were immobilized
for 30 minutes with the ambient temperature increased
to 30C. For individual animals, at least three tail-cuff
measurements with no movement-generated artifacts
were obtained from a maximum of eight inflations. The
averages of these values were then used for statistical
analyses. In one nicotine SHR and one nicotine BN, we
were unable to obtain BP and HR measurements using
the above manner. All BP and HR recordings were read
by two independent raters.
The animals were sacrificed 48 hours after the BP and
HR measurements and following an overnight fast. The
heart, kidneys, and liver were removed. The heart and
kidneys were weighed; values corrected for the body
weight were subjected to statistical analyses. Sera were
collected and frozen for the measurement of glucose, insu-
lin, cholesterol, and triglyceride (TG) concentrations. The
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Fig. 1. (A ) Systolic and (B ) diastolic blood
pressure, (C ) mean arterial pressure, and (D )
heart rate measured by the tail-cuff method in
nine-week-old male spontaneously hypertensive
rats (SHR) and normotensive Brown Norway
(BN) rats exposed to nicotine and saline during
intrauterine development. The within-strain ef-
fect of nicotine exposure was evaluated by the
two-sided t test.
collected organs were snap-frozen and stored for gene
expression analyses.
Total RNA was extracted from the whole kidneys and
from a segment of the liver [19]. Expression of the insulin-
like growth factor (IGF)-1 and IGF receptor (IGFR)
genes was determined by semi-quantitative reverse tran-
scription-polymerase chain reaction (RT-PCR; Quan-
tumRNA Classic II Internal Standards Kit, Ambion,
Inc., Austin, TX, USA). All reactions were carried out
in duplicate.
The within-strain effects of nicotine exposure were
evaluated by the two-sided t test (StatView, SAS Insti-
tute, Inc., Cary, NC, USA). Statistical results with P
values0.05 were regarded as significant. Power calcula-
tions were performed with DSS Research software (Fort
Worth, TX, USA; www.dssresearch.com).
RESULTS
Impact of the intrauterine nicotine exposure on BP
and HR at the age of nine weeks
At nine weeks of age, SBP measured by the tail-cuff
method was significantly higher (P  0.02) in SHR ex-
posed in utero to nicotine than in SHR exposed to saline.
No significant difference between nicotine and saline
rats was observed in the BN strain (Fig. 1A). For DBP,
mean arterial pressure, and HR, no significant differ-
ences between nicotine and saline rats were seen in either
strain (Fig. 1 B to D). These data suggest that exposure
to nicotine during intrauterine development is associated
with increased SBP at the age of nine weeks, but only
in SHR.
Impact of the intrauterine nicotine exposure on
cardiovascular organ size at the age of nine weeks
In both strains of rats, intrauterine nicotine exposure
resulted in a nonsignificant body-weight (BW) decrease
(P  0.08 and P  0.1, respectively) (Fig. 2A). In con-
trast, strain-differential responses to the nicotine expo-
sure were observed for heart weight (HW) and kidney
weight (KW) (Fig. 2 B and C). In SHR, nicotine, as com-
pared to saline rats, demonstrated a nonsignificant decrease
in HW (P  0.06) and a highly significant decrease in
KW (P  0.0001). In BN rats, in contrast, no significant
differences between nicotine and saline rats were seen
(HW, P  0.4; KW, P  0.07) (Fig. 2 B and C). These
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Fig. 2. (A) Body weight and relative (B) heart
and (C) kidney weights in nine-week-old male
normotensive Brown Norway (BN) rats and
spontaneously hypertensive rats (SHR) exposed
to nicotine and saline during intrauterine de-
velopment. The within-strain effect of nicotine
exposure was evaluated by the two-sided t test.
data demonstrate that intrauterine nicotine exposure is
associated with reduced KW in SHR and no significant
effect in BN rats.
It has been shown that during renal development, the
IGF system is involved in the regulation of kidney
growth. It has been also shown that later in life, IGF-1
may contribute to the regulation of compensatory renal
growth and the development of renal hypertrophy, with
local and/or circulating IGF involvement [20]. Therefore,
we examined gene expression of IGF-1 (Fig. 3A) and
its receptor, IGFR, in the kidneys. In addition, since the
major source of circulating IGF-1 is the liver, we ana-
lyzed gene expression of IGF-1 in the liver. These analy-
ses showed that in the BN strain, IGFR expression in
the kidneys (Fig. 3B), and IGF-1 expression in the liver
(Fig. 3C) were significantly up-regulated in rats exposed
to nicotine as compared to rats exposed to saline. No sig-
nificant differences were observed in SHR (Fig. 3). It is
of note, however, that the levels of IGFR expression in
the kidneys were marginally (P  0.07) lower in the
SHR exposed to nicotine, compared with saline; power
calculations indicate that adding one animal per group
would make this difference significant (P  0.05).
Impact of the intrauterine nicotine exposure on
glucose and lipid metabolism at the age of nine weeks
In both strains of rats, intrauterine exposure to nico-
tine was not associated with a significant impact on the
ratio of glucose to insulin levels (Fig. 4A). In SHR, how-
ever, the ratio was marginally (P 0.1) lower in nicotine
than in saline rats; power calculations indicate that add-
ing two animals per group would make this difference
significant (P  0.05). Serum TG levels were slightly
higher in nicotine rats than in saline rats, but only in the
BN strain (P  0.05) (Fig. 4B), and serum cholesterol
levels were significantly higher in nicotine than in saline
rats, but only in the SHR strain (P  0.01) (Fig. 4C).
Together, the data demonstrate that intrauterine nico-
tine exposure impacts lipid metabolism in a strain-differ-
ential manner; it leads to a modest increase of serum
TG in BN rats and a significant elevation of serum choles-
terol in SHR.
DISCUSSION
The results of the present study demonstrate that, in
male rats, intrauterine exposure to nicotine significantly
impacts the cardiovascular and metabolic systems and
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Fig. 3. The (A and B ) kidney and (C ) liver
expression of the insulin-like growth factor
(IGF)-1 and IGF receptor (IGFR) genes in nine-
week-old male Brown Norway (BN) rats and
spontaneously hypertensive rats (SHR) exposed
to nicotine and saline during intrauterine de-
velopment. The within-strain effect of nicotine
exposure was evaluated by the two-sided t test.
Fig. 4. (A ) Glucose and (B and C ) lipid me-
tabolism in nine-week-old male Brown Nor-
way (BN) rats and spontaneously hyperten-
sive rats (SHR) exposed to nicotine and saline
during intrauterine development. The within-
strain effect of nicotine exposure was evalu-
ated by the two-sided t test.
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that genetic background modifies this impact. More spe-
cifically, intrauterine nicotine exposure influenced sig-
nificantly BP, KW, lipid metabolism, and gene expres-
sion of the IGF system assessed at the age of nine weeks,
and these effects differed between two genetically dis-
tinct strains of rats, namely SHR and BN. When com-
pared to the control (saline) rats, SHR exposed to nico-
tine in utero exhibited an increase in SBP and serum
cholesterol, and a decrease in KW. BN rats, in contrast,
showed no effect of in utero exposure to nicotine at the
above parameters, but demonstrated a significant up-
regulation of the IGF system.
The results of our investigation are consistent with
epidemiologic studies reporting that intrauterine expo-
sure to maternal tobacco smoking is associated with an
elevation of BP later in life [10–12]. Not all previous
investigations have found such a relationship, however.
The present study provides one possible explanation for
the discordance, as it demonstrates that the impact of
intrauterine nicotine exposure on BP differs substantially
between genetically distinct strains. This suggests that
genetic background plays an important role in determin-
ing whether an individual is or is not susceptible to the
BP-elevating effects of intrauterine nicotine exposure.
In the current investigation, intrauterine nicotine ex-
posure resulted in a reduction of KW and an augmen-
tation of SBP in SHR. It has been suggested previously
that suppression of kidney growth by an adverse intra-
uterine environment may play an important role in the
pathogenesis of hypertension later in life [1]. Consis-
tently, intrauterine growth retardation induced by a low-
protein diet has been related to reduced KW and glomer-
ular number and increased BP in the rat [21]. These
changes have been associated with altered renin-aldoste-
rone axis functioning [22], sodium retention, and ex-
panded extracellular volume [23]. More recently, tran-
scriptional up-regulation of specific sodium transporters
in the thick ascending limb and distal convoluted tubule
has been described in this model [24].
In the developed world, maternal cigarette smoking
during pregnancy is the leading cause of intrauterine
growth retardation [9]. IGF-1 is an essential regulator
of fetal growth and appears to be negatively affected by
maternal cigarette smoking. It has been shown that IGF-1
concentrations in umbilical cord serum were significantly
lower in neonates born to cigarette-smoking mothers than
in neonates born to non-smoking mothers [25]. Further-
more, the IGF system appears to be involved in kidney
growth during renal development and, later in life, may
contribute to compensatory renal growth and renal hy-
pertrophy [20]. In addition, in rats with acute renal fail-
ure, administration of IGF-1 accelerates the recovery
of renal function [20]. In the present study, intrauterine
exposure to nicotine was associated with transcriptional
up-regulation of the IGF system in the kidneys of nine-
week-old BN rats, but not in the kidneys of SHR of the
same age. With respect to KW, in utero exposure to
nicotine was associated with a reduction in SHR but not
in BN rats. It is tempting to speculate that the IGF up-
regulation in BN rats prevented the nicotine-induced
reduction in the KW in this strain; further studies are
necessary to confirm such a link.
The maternal nicotine infusion employed here may
affect the developing fetus in two principal ways. First,
nicotine readily gains access to the fetal compartment
where its concentration is 15% higher than that in the
maternal circulation [16]; in this way, nicotine may have
direct effects on the cellular growth and the activity of
the central and peripheral nervous systems [17]. Second,
nicotine may influence the fetus indirectly through its
effects on the mother. For example, in both animal mod-
els and humans, nicotine increases maternal BP and HR,
which in turn leads to a concomitant reduction in uterine
blood flow and decreased supply of nutrients and oxygen
to the fetus [16]. BP, volume homeostasis, and renal
function during gestation differ between normotensive
and hypertensive rat strains [26]. Nicotine administration
to the dams during pregnancy, and its discontinuation
just before delivery, could have also influenced maternal
behavior in the early postnatal period [27, 28]. One of
the limitations of this study is the small number of treated
dams. Further studies are necessary to confirm our initial
findings and to identify pathophysiologic pathways lead-
ing to the development of the observed phenotypes.
CONCLUSION
The results of the present experiments demonstrate
that intrauterine exposure to nicotine significantly affects
the cardiovascular and metabolic systems in early adult-
hood, and that genetic background modifies this impact.
Our data provide further evidence that the intrauterine
environment, in interaction with genes, plays a critical role
in determination of an individual’s health later in life.
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